Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects

AMD070 is an oral CXCR4 antagonist with in vitro activity against X4-tropic human immunodeficiency virus type 1. Thirty fasting healthy male volunteers received oral doses of AMD070 ranging from a single 50-mg dose to seven 400-mg doses given every 12 h (q12h). Nine subjects received a 200-mg dose d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stone, Nimalie D., Dunaway, Shelia B., Flexner, Charles, Tierney, Camlin, Calandra, Gary B., Becker, Stephen, Cao, Ying-Jun, Wiggins, Ilene P., Conley, Jeanne, MacFarland, Ron T., Park, Jeong-Gun, Lalama, Christina, Snyder, Sally, Kallungal, Beatrice, Klingman, Karin L., Hendrix, Craig W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2007
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1913234/
https://ncbi.nlm.nih.gov/pubmed/17452489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00013-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados